Shenzhen Neptunus Bioengineering Co., Ltd.
|
36.41 Billion CNY
|
98.017%
|
Anhui Fengyuan Pharmaceutical Co., Ltd.
|
4.27 Billion CNY
|
83.11%
|
Dong-E-E-Jiao Co.,Ltd.
|
4.71 Billion CNY
|
84.685%
|
Livzon Pharmaceutical Group Inc.
|
12.27 Billion CNY
|
94.119%
|
Hainan Haiyao Co., Ltd.
|
1.45 Billion CNY
|
50.444%
|
Tus-Pharmaceutical Group Co., Ltd.
|
395.92 Million CNY
|
-82.394%
|
Jilin Aodong Pharmaceutical Group Co., Ltd.
|
3.44 Billion CNY
|
79.063%
|
Changchun High-Tech Industries (Group) Inc.
|
14.46 Billion CNY
|
95.006%
|
Apeloa Pharmaceutical Co.,Ltd
|
11.47 Billion CNY
|
93.706%
|
PKU HealthCare Corp.,Ltd.
|
2.19 Billion CNY
|
67.083%
|
Chengdu Huasun Technology Group Inc., Ltd.
|
1 Billion CNY
|
28.029%
|
Dezhan Healthcare Company Limited
|
498.08 Million CNY
|
-44.982%
|
Jinling Pharmaceutical Company Limited
|
2.78 Billion CNY
|
74.077%
|
Jiuzhitang Co., Ltd.
|
2.91 Billion CNY
|
75.264%
|
Huapont Life Sciences Co., Ltd.
|
11.59 Billion CNY
|
93.772%
|
Zhejiang Jingxin Pharmaceutical Co., Ltd.
|
3.95 Billion CNY
|
81.728%
|
Shandong Wohua Pharmaceutical Co., Ltd.
|
894.31 Million CNY
|
19.252%
|
Hengkang Medical Group Co., Ltd.
|
3.59 Billion CNY
|
79.887%
|
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
|
2.61 Billion CNY
|
72.338%
|
Qianjiang Yongan Pharmaceutical Co., Ltd.
|
962.8 Million CNY
|
24.996%
|
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
|
5.42 Billion CNY
|
86.681%
|
Jinhe Biotechnology CO., LTD.
|
2.17 Billion CNY
|
66.785%
|
Teyi Pharmaceutical Group Co.,Ltd
|
1.06 Billion CNY
|
32.334%
|
Kunming Longjin Pharmaceutical Co., Ltd.
|
86.62 Million CNY
|
-733.662%
|
Beijing Aosaikang Pharmaceutical Co., Ltd.
|
1.44 Billion CNY
|
49.972%
|
Chengdu Kanghong Pharmaceutical Group Co., Ltd
|
3.95 Billion CNY
|
81.752%
|
Anhui Huangshan Capsule Co., Ltd.
|
458.36 Million CNY
|
-57.545%
|
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
|
980.82 Million CNY
|
26.375%
|
Zhuhai Rundu Pharmaceutical Co., Ltd.
|
1.29 Billion CNY
|
44.102%
|
Huaren Pharmaceutical Co., Ltd.
|
1.63 Billion CNY
|
55.866%
|
Tianjin Ringpu Bio-Technology Co.,Ltd.
|
2.24 Billion CNY
|
67.89%
|
Shanxi Zhendong Pharmaceutical Co.,Ltd
|
3.62 Billion CNY
|
80.085%
|
Fuan Pharmaceutical (Group) Co., Ltd.
|
2.64 Billion CNY
|
72.726%
|
Hybio Pharmaceutical Co., Ltd.
|
431.38 Million CNY
|
-67.4%
|
Baotou Dongbao Bio-Tech Co.,Ltd
|
974.51 Million CNY
|
25.897%
|
Hunan Er-Kang Pharmaceutical Co., Ltd
|
1.76 Billion CNY
|
59.183%
|
Changjiang Pharmaceutical Group Co., Ltd.
|
1.19 Billion CNY
|
39.699%
|
Zhejiang Garden Bio-chemical High-tech Co., Ltd.
|
1.09 Billion CNY
|
34.03%
|
Fujian Cosunter Pharmaceutical Co., Ltd.
|
422.71 Million CNY
|
-70.834%
|
Beijing Science Sun Pharmaceutical Co., Ltd.
|
476.56 Million CNY
|
-51.528%
|
Zhejiang Xinguang Pharmaceutical Co., Ltd.
|
270.39 Million CNY
|
-167.063%
|
Hainan Poly Pharm. Co., Ltd
|
1.3 Billion CNY
|
44.642%
|
Wuhan Hiteck Biological Pharma Co.,Ltd
|
602.28 Million CNY
|
-19.9%
|
Shandong Xinhua Pharmaceutical Company Limited
|
8 Billion CNY
|
90.983%
|
Zhejiang Tianyu Pharmaceutical Co., Ltd.
|
2.52 Billion CNY
|
71.426%
|
PharmaBlock Sciences (Nanjing), Inc.
|
1.72 Billion CNY
|
58.142%
|
Jinghua Pharmaceutical Group Co., Ltd.
|
1.49 Billion CNY
|
51.549%
|
Zhejiang Hisoar Pharmaceutical Co., Ltd.
|
2.17 Billion CNY
|
66.751%
|
Betta Pharmaceuticals Co., Ltd.
|
2.45 Billion CNY
|
70.599%
|
Tibet AIM Pharm. Inc.
|
667.03 Million CNY
|
-8.26%
|
Shenzhen Kangtai Biological Products Co., Ltd.
|
3.47 Billion CNY
|
79.234%
|
Shandong Shanda Wit Science and Technology Co., Ltd.
|
2.48 Billion CNY
|
70.93%
|
Pacific Shuanglin Bio-pharmacy Co., LTD
|
2.32 Billion CNY
|
68.99%
|
Zhejiang AngLiKang Pharmaceutical CO.,LTD.
|
1.62 Billion CNY
|
55.584%
|
Xiamen Kingdomway Group Company
|
3.1 Billion CNY
|
76.725%
|
ShanXi C&Y Pharmaceutical Group Co., Ltd.
|
799.3 Million CNY
|
9.654%
|
Walvax Biotechnology Co., Ltd.
|
4.11 Billion CNY
|
82.446%
|
Sunflower Pharmaceutical Group Co.,Ltd
|
5.63 Billion CNY
|
87.177%
|
Harbin Gloria Pharmaceuticals Co., Ltd
|
2.58 Billion CNY
|
72.117%
|
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
|
24.73 Billion CNY
|
97.081%
|
Hunan Hansen Pharmaceutical Co., Ltd.
|
955.53 Million CNY
|
24.425%
|
Changzhou Qianhong Biopharma CO.,LTD
|
1.79 Billion CNY
|
59.744%
|
Shenzhen Weiguang Biological Products Co., Ltd.
|
1.04 Billion CNY
|
31.127%
|
Honz Pharmaceutical Co., Ltd.
|
739.56 Million CNY
|
2.357%
|
Northeast Pharmaceutical Group Co., Ltd.
|
8.16 Billion CNY
|
91.152%
|
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
|
1.46 Billion CNY
|
50.629%
|
Guizhou Xinbang Pharmaceutical Co., Ltd.
|
6.46 Billion CNY
|
88.823%
|
Tianjin Lisheng Pharmaceutical Co.,Ltd.
|
1.13 Billion CNY
|
36.103%
|
Zhejiang Yatai Pharmaceutical Co., Ltd.
|
420.64 Million CNY
|
-71.675%
|
Zhejiang NHU Company Ltd.
|
15.11 Billion CNY
|
95.223%
|
ApicHope Pharmaceutical Co., Ltd
|
2.5 Billion CNY
|
71.154%
|
Shanghai Kaibao Pharmaceutical CO.,Ltd
|
1.59 Billion CNY
|
54.698%
|
Beijing SL Pharmaceutical Co., Ltd.
|
1.01 Billion CNY
|
29.088%
|
Yunnan Baiyao Group Co.,Ltd
|
38.9 Billion CNY
|
98.144%
|
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD
|
1.08 Billion CNY
|
33.138%
|
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
|
839.25 Million CNY
|
13.955%
|
Guangdong Lifestrong Pharmacy Co., Ltd.
|
292.39 Million CNY
|
-146.972%
|
Huadong Medicine Co., Ltd
|
40.39 Billion CNY
|
98.212%
|
Jiangsu Nhwa Pharmaceutical Co., LTD
|
4.97 Billion CNY
|
85.48%
|
Harbin Medisan Pharmaceutical Co., Ltd.
|
1.18 Billion CNY
|
39.152%
|
LanZhou Foci Pharmaceutical Co.,Ltd.
|
1.16 Billion CNY
|
37.914%
|
Tianjin Chase Sun Pharmaceutical Co.,Ltd
|
6.12 Billion CNY
|
88.214%
|
Beijing Beilu Pharmaceutical Co., Ltd
|
890.71 Million CNY
|
18.926%
|
Nanjing Hicin Pharmaceutical Co., Ltd.
|
517.83 Million CNY
|
-39.454%
|
Renhe Pharmacy Co., Ltd.
|
5.03 Billion CNY
|
85.649%
|
Chongqing Pharscin Pharmaceutical Co., Ltd.
|
691.54 Million CNY
|
-4.424%
|
Zhejiang Xianju Pharmaceutical Co.,Ltd.
|
4.12 Billion CNY
|
82.487%
|
Luoxin Pharmaceuticals Group Stock Co., Ltd.
|
2.34 Billion CNY
|
69.174%
|
Guizhou Bailing Group Pharmaceutical Co., Ltd.
|
4.26 Billion CNY
|
83.06%
|